+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Edoxaban Tosilate Tablets & Generic Drugs Market - Global Forecast 2025-2030- Product Image
Edoxaban Tosilate Tablets & Generic Drugs Market - Global Forecast 2025-2030- Product Image
Sale

Edoxaban Tosilate Tablets & Generic Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6134326
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The anticoagulant market is at a pivotal moment, shaped by demographic trends and an increased focus on patient outcomes. Edoxaban Tosilate Tablets have become a critical therapy, driving significant shifts across treatment paradigms and competitive dynamics.

Market Snapshot: Edoxaban Tosilate Tablets Market Overview

The Edoxaban Tosilate Tablets market has witnessed dynamic transformation over the last decade, driven by an aging population, a rise in cardiovascular disease prevalence, and the movement toward patient-centric care models. Recent years have seen direct oral anticoagulants, specifically Edoxaban Tosilate Tablets, gain traction as essential alternatives for stroke prevention in atrial fibrillation, as well as therapy and prevention of recurrent deep vein thrombosis and pulmonary embolism. The expiration of key patents is accelerating market entry for generics, triggering fiercer competition and a reassessment of value, procurement, and supply strategies by both established brands and new entrants.

Scope & Segmentation: Market Landscape and Analysis

  • Product Type: Brand, Generic
  • Distribution Channel: Hospital Pharmacy (Private, Public), Online Pharmacy (Manufacturer Portal, Pharmacy Portal), Retail Pharmacy (Chain Pharmacy, Independent Pharmacy)
  • Therapeutic Application: Prevention of Recurrence of DVT and PE, Stroke Prevention in Atrial Fibrillation, Treatment of Deep Vein Thrombosis and Pulmonary Embolism
  • Dosage Strength: 15 mg, 30 mg
  • End User: Outpatient Clinic, Specialty Clinic, Assisted Home Healthcare, Self-Administered Home Healthcare, Inpatient Hospital Department, Outpatient Hospital Department
  • Region: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering United Kingdom, Germany, France, Saudi Arabia, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, and select Southeast Asian markets)
  • Enabling Technologies: Digital health platforms, telemedicine, remote patient monitoring, real-world evidence platforms, continuous manufacturing, advanced analytics, regulatory harmonization initiatives
  • Key Manufacturers: Daiichi Sankyo Co., Ltd.; Takeda Pharmaceutical Company Limited; Teva Pharmaceutical Industries Ltd.; Sandoz International GmbH; Viatris Inc.; Sun Pharmaceutical Industries Limited; Dr. Reddy’s Laboratories Limited; Lupin Limited; Aurobindo Pharma Limited; Cipla Limited

Key Takeaways: Strategic Insights for Senior Leaders

  • Edoxaban Tosilate Tablets are reshaping anticoagulant therapy, leading the transition from vitamin K antagonists to direct oral anticoagulants that improve patient adherence and simplify dosing protocols.
  • Market competition is intensifying as generic manufacturers enter, compelling both innovators and generics to create clear value propositions focusing on either lifecycle management or cost efficiency.
  • Regional variation is apparent: In the Americas, sophisticated reimbursement and data-driven contracting are common, while Europe, Middle East & Africa, and Asia-Pacific show differing regulatory and access barriers that demand tailored approaches from manufacturers.
  • Increasing adoption of digital monitoring, telehealth, and predictive analytics is enhancing personalized care, optimizing therapeutic windows, and supporting superior patient outcomes.
  • Distribution channel strategies must account for differences in procurement behaviors between hospital, retail, and online pharmacies, each offering distinct opportunities for engagement and patient reach.
  • Manufacturers are leveraging technological advances such as continuous manufacturing and real-world evidence platforms to boost operational efficiency, ensure quality, and strengthen market positions.

Tariff Impact: United States 2025 Tariff Adjustments

Forthcoming tariff reforms in the United States are set to increase costs for imported active pharmaceutical ingredients required for Edoxaban Tosilate Tablets. Companies are actively mitigating risks through dual-sourcing, domestic manufacturing expansion, strategic inventory management, and closer collaboration with regulatory bodies. These measures aim to preserve supply chain continuity amid changing trade policies and safeguard margins against rising input costs.

Methodology & Data Sources

Insights in this report derive from a rigorous, multi-source research methodology encompassing primary interviews with industry leaders, regulatory specialists, and key opinion leaders, as well as comprehensive secondary research leveraging peer-reviewed studies, regulatory filings, and sector publications. Combined qualitative and quantitative analysis frameworks, including SWOT and PESTLE, ensure reliable, actionable findings.

Why This Report Matters

  • Provides senior decision-makers with clear, actionable intelligence to navigate evolving regulatory, technology, and competitive trends in the anticoagulant sector.
  • Enables quick identification of segment-specific opportunities, risk mitigation strategies, and regional growth drivers in an increasingly competitive market.
  • Supports evidence-based planning, supply chain optimization, and positioning for value-based procurement models.

Conclusion

Edoxaban Tosilate Tablets and generic anticoagulants are at the forefront of a changing therapeutic and business landscape. Informed, adaptive strategies and robust stakeholder collaboration will be vital for sustained leadership and patient value.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of Edoxaban tosylate tablets driven by favorable safety outcomes and reduced monitoring requirements compared with traditional anticoagulants
5.2. Entry of multiple Edoxaban tosylate generic formulations intensifying pricing competition and market fragmentation
5.3. Strategic alliances between originator manufacturers and generic drug companies expanding Edoxaban access in emerging markets
5.4. Regulatory approvals for new Edoxaban indications including extended prophylaxis in cancer associated thrombosis driving market expansion
5.5. Escalating patent expiry timelines and ongoing litigation shaping generic entry schedules and exclusivity periods for Edoxaban tablets
5.6. Growing focus on digital health interventions and patient adherence programs to optimize outcomes in Edoxaban tosylate therapy
5.7. Supply chain disruptions and raw material shortages impacting the global availability and pricing stability of Edoxaban tosylate tablets
5.8. Development of fixed dose combination therapies incorporating Edoxaban with antiplatelet agents aiming to enhance thromboprophylaxis efficacy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Edoxaban Tosilate Tablets & Generic Drugs Market, by Product Type
8.1. Introduction
8.2. Brand
8.3. Generic
9. Edoxaban Tosilate Tablets & Generic Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.2.1. Private Hospital
9.2.2. Public Hospital
9.3. Online Pharmacy
9.3.1. Manufacturer Portal
9.3.2. Pharmacy Portal
9.4. Retail Pharmacy
9.4.1. Chain Pharmacy
9.4.2. Independent Pharmacy
10. Edoxaban Tosilate Tablets & Generic Drugs Market, by Therapeutic Application
10.1. Introduction
10.2. Prevention Of Recurrence Of Dvt Pe
10.3. Stroke Prevention In Atrial Fibrillation
10.4. Treatment Of Deep Vein Thrombosis And Pulmonary Embolism
11. Edoxaban Tosilate Tablets & Generic Drugs Market, by Dosage Strength
11.1. Introduction
11.2. 15 Mg
11.3. 30 Mg
12. Edoxaban Tosilate Tablets & Generic Drugs Market, by End User
12.1. Introduction
12.2. Clinic
12.2.1. Outpatient Clinic
12.2.2. Specialty Clinic
12.3. Home Healthcare
12.3.1. Assisted Administration
12.3.2. Self Administration
12.4. Hospital
12.4.1. Inpatient Department
12.4.2. Outpatient Department
13. Americas Edoxaban Tosilate Tablets & Generic Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Edoxaban Tosilate Tablets & Generic Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Edoxaban Tosilate Tablets & Generic Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Daiichi Sankyo Co., Ltd.
16.3.2. Takeda Pharmaceutical Company Limited
16.3.3. Teva Pharmaceutical Industries Ltd.
16.3.4. Sandoz International GmbH
16.3.5. Viatris Inc.
16.3.6. Sun Pharmaceutical Industries Limited
16.3.7. Dr. Reddy’s Laboratories Limited
16.3.8. Lupin Limited
16.3.9. Aurobindo Pharma Limited
16.3.10. Cipla Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET: RESEARCHAI
FIGURE 26. EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY BRAND, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY BRAND, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY MANUFACTURER PORTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY MANUFACTURER PORTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PHARMACY PORTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PHARMACY PORTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PREVENTION OF RECURRENCE OF DVT PE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PREVENTION OF RECURRENCE OF DVT PE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY STROKE PREVENTION IN ATRIAL FIBRILLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY TREATMENT OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY TREATMENT OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY 15 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY 15 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY 30 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY 30 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ASSISTED ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ASSISTED ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY INPATIENT DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY INPATIENT DEPARTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY OUTPATIENT DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY OUTPATIENT DEPARTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 138. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 139. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 142. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 143. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 146. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 147. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 148. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 149. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 150. CANADA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 151. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 164. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 165. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 168. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 169. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 172. MEXICO EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 263. GERMANY EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. GERMANY EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. GERMANY EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. GERMANY EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. GERMANY EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 268. GERMANY EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 269. GERMANY EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 270. GERMANY EDOXABAN TOSILATE TABLETS & GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 271. G

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Edoxaban Tosilate Tablets & Generic Drugs market report include:
  • Daiichi Sankyo Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Sun Pharmaceutical Industries Limited
  • Dr. Reddy’s Laboratories Limited
  • Lupin Limited
  • Aurobindo Pharma Limited
  • Cipla Limited

Related Topics

Related Reports

Oral Factor Xa Inhibitors Market - Global Forecast 2025-2030 - Product Image

Oral Factor Xa Inhibitors Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Factor Xa Inhibitors Market - Global Forecast 2025-2030 - Product Image

Factor Xa Inhibitors Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Factor Xa Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Factor Xa Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Apixaban - Global Strategic Business Report - Product Image

Apixaban - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Factor Xa Inhibitor Market - A Global and Regional Analysis: Focus on Application, Route of Administration, and Region - Analysis and Forecast, 2025-2035 - Product Image

Factor Xa Inhibitor Market - A Global and Regional Analysis: Focus on Application, Route of Administration, and Region - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.